Buzz Stocks: Rite Aid Corporation, Merck & Co., Inc., and Nu Skin Enterprises, Inc.

Today's stocks to watch in the news include Rite Aid Corporation (NYSE:RAD), Merck & Co., Inc. (NYSE:MRK), and Nu Skin Enterprises, Inc. (NYSE:NUS)

Jun 16, 2016 at 9:24 AM
facebook twitter linkedin

U.S. stocks are set to open in the red, as investors consider the latest round of central bank decisions. Among the equities in focus today are pharmacy chain Rite Aid Corporation (NYSE:RAD), drugmaker Merck & Co., Inc. (NYSE:MRK), and personal care stock Nu Skin Enterprises, Inc. (NYSE:NUS)

  • RAD is down 1.5% ahead of the open, after the company's disappointing first-quarter earnings results. The stock has traded in a tight range this year, as traders await a decision in its pending M&A deal. Specifically, Rite Aid Corporation closed last night at $7.82, just below its 2016 breakeven mark of $7.84. In the meantime, call buying has remained popular at the International Securities Exchange (ISE), Chicago Board Options Exchange (CBOE), and NASDAQ OMX PHLX (PHLX). The stock's 50-day call/put volume ratio across these exchanges stands at 2.02. 
  • NUS is eyeing a 3% pop out of the gate, after the company agreed to a $210 million investment from a group of Chinese investors -- a move meant to help the company grow its presence in China. Nu Skin Enterprises, Inc. has performed well on the charts recently, surging more than 73% since its February bottom of $23.51, to trade at $40.69. Short interest has been declining as a result, and NUS could benefit from a short-squeeze situation going forward, since these bears still control close to three weeks' worth of buying power, at the stock's average daily volumes. 
Sign up now for Schaeffer's Opening View newsletter to get a head start on all the major pre-market news!

Now is the time to join our thriving community of Event Traders who consistently profit from every earnings season. With this discounted subscription opportunity, you'll stay ahead of the curve and seize opportunities others miss. Do not let Q3 earnings season pass you by – subscribe now and supercharge your portfolio with expert insights that turn market reactions into profit-generating opportunities!! Don't waste another second... join us right now before the next trade targeting +200% is released!